Why Life Science Companies Surged amid a Global M&A Downturn
#2
#3
#4
#5
#1
#2
CDMO
Dec 04, 2024
Advancing the Science of Technical and Therapeutic Proteins
#3
#4
#5
RoundTable Topics
D
Outsourcing Dynamics
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
J
Jeanne Hecht
I
Ian Scanlon
R
Ryan Guest, Ph.D.
J
Jaewon Mun
S
Sonya Schermann, Ph.D.
Enhanced data analytics, AI, and machine learning are transforming drug discovery and development by enabling more accurate predictions of drug efficacy and safety
Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?
I
Isabelle de Cremoux
S
Sidonie Golombowski-Daffner, Ph.D.
P
Phil Vanek
M
Marrie Groeneveld
A
Alen Guy
I believe that the focus on the microbiome will significantly increase in 2021 and beyond. The pandemic hardly disrupted microbiome research, and 2020 saw an increasing level of investment and partnering in this area.
